Biosimilars
Companies working to replicate original biologic drugs and distribute them globally at lower prices.
+0.15% today·7 stocks
Stocks
By market cap · 7 stocks
- 1
NVSNovartis (ADR)Developer of focused innovative medicines$267.96B+0.22% - 2
PFEPfizerDeveloper of Eliquis, Prevnar and cancer medicines$158.10B+0.54% - 3
GSKGSK (ADR)Developer of Shingrix, Nucala, and Trelegy$102.34B−0.62% - 4
VTRSViatrisGlobal maker of established brands and generics$19.91B+0.07% - 5
ALVOAlvotechIntegrated developer and manufacturer of biosimilars$1.99B−0.26% - 6
CHRSCoherus OncologyLOQTORZI-centered immuno-oncology developer$211.7M−2.84% - 7
AEONAEON BiopharmaTherapeutic Botox biosimilar developer$11.2M+1.77%